ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q2SCImago #7,987Diamond OAHybrid

Infection and Chemotherapy

Identifier (ISSN):2093-2340(Print)/2092-6448(Online)
•
Publisher:Jin Publishing & Printing Co.
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2.4↓ -0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Infection and Chemotherapy

WoS Q3
13464.220232.820242.920252.42026
Annual Impact Factor Metric
Current (2026):2.4
Scopus SJR & RankScopus Q2
0.719
#7,987

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
44

44 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate17.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
70articles/year
97.53% Gold OA•80% Original Research

Aims & Scope

Infection and Chemotherapy (ISSN: 2093-2340) is a peer-reviewed international scholarly journal in the field of INFECTIOUS DISEASES, published by Jin Publishing & Printing Co. in Korea, Republic Of. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.719 (Q2), an H-index of 44.

Topics Covered (Recognized by AI)
MedicineBiologyGeneticsInternal MedicinePathologyImmunologyChemistryMicrobiologyBiochemistrySurgeryVirologyIntensive Care MedicineGeologyPaleontologyBacteriologyPathology & Diseases
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

INFECTIOUS DISEASES

Q3
Rank80/141
IndexESCI
JCIESCI2026

INFECTIOUS DISEASES

Q3
Rank72/141
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.4
Articles / Year29
Total Citations1
2025
IF2.9
Articles / Year86
Total Citations105
2024
IF2.8
Articles / Year71
Total Citations325
2023
IF4.2
Articles / Year65
Total Citations382
2022
IF—
Articles / Year101
Total Citations1,027

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,987Scopus Q2Diamond OASCImago Profile
Scopus Coverage:2011-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.719

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.87

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations448
3-Year Documents224
Citable Documents168

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate55.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ2
Pharmacology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 17.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
4区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Infection and Chemotherapy (ISSN: 2093-2340) is a peer-reviewed international scholarly journal in the field of INFECTIOUS DISEASES, published by Jin Publishing & Printing Co. in Korea, Republic Of. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.719 (Q2), an H-index of 44.

The journal enforces rigorous peer evaluation with an annual output of approximately 70 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Jin Publishing & Printing Co.
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 1deb40d6-84f2-4f3b-9b13-2cefd26d4755
Database Updated: 2026-09-28